Member Info for Sheephatch

I feel this is a little shake going on for the nervous. Nothing changed and news now very imminent. Good luck.

Looking like blue coming

I’d say huge. Very positive looking.

Good luck

To everyone who has just arrived this is undervalued. IRON was at 5p and 6p a few years ago and we’ve now moved on considerably. After much hard work in an increadably difficult environment the team at IRON have got us producing a world class product which is ever increasing in value.
Next RNS will in my opinion confirm our future and then a real rise in the SP expected. I pesonaly see a return to the 6p plus range very realistic. Good luck.

Guys whilst SXX is one of my long term holdings if you want to have a quick look at IRON things are warming up very nicely. RNS coming shortly and large increase in the very low SP anticipated. Worth a look. Good luck.

Hold onto your hats. Things starting to happen. Good luck all. 3p very soon !

Interesting start to the day. Good luck.

Some great buys today. I think we would be 15p plus if it wasn’t for Brexit and other uncertainty. Good luck.

Doctors need to double the dose of antibiotics they give to patients with gonorrhoea because it's becoming resistant to medicine, experts have warned.

The British Association for Sexual Health and HIV (BASHH) today issued new guidelines for treating the STI for the first time since 2011.

Its recommendations follow news released earlier this month that two women in the UK caught 'super gonorrhoea' - one of whom was the first to ever catch it in Britain.

BASHH urges doctors to stop using one of the routine antibiotics and to increase the dose of another in what it called 'a major change'.

Let’s hope for a repeat

In September 2008, Duggan was appointed CEO of Pharmacyclics, a California-based biopharmaceutical company that was founded in 1991. At the time, Pharmacyclics had a market capitalization of $15 million and was on the brink of collapse. Duggan, who was the company’s largest shareholder with 24.1% of the outstanding stock, took on the challenge of turning around the failing firm which he once described in retrospect as a "collision course to disaster." He began accumulating shares in the company in 2004 when the stock traded around $10. From then to mid-2007, the stock fell to as low as $3 per share due to a number of internal issues. Instead of cutting his losses by selling what little value the stock had left, Duggan stuck it through and continued purchasing more shares.

During his tenure from 2008-2015, Duggan saved Pharmacyclics and turned it into a billion-dollar company with more than 500 employees. The turn of events was mainly influenced by a successful drug the company developed called Imbruvica. It was a treatment for chronic lymphocytic leukemia. As a result, Pharmacyclics’ stock price dramatically increased, making Duggan a billionaire by 2014. In 2015, AbbVie announced it would be acquiring Pharmacyclics for $21 billion. Duggan grossed $3.4 billion from the sale.

More good news from the hardworking team at OPTI. More deals soon I would imagine and the SP will reflect as soon as the numbers make a positive statement. With every deal this company gets stronger and the risks if there are any to be honest will reduce. One of the most exciting companies on AIM and a terrific short, medium and long term company out there in my opinion. Potentially multiple returns for investors in due course. Patience will be rewarded.

Big year ahead here and at OPTI. Next Tuesdays Brexit vote to get out the way first and then I think things will pick up nicely if May gets it through. If not we might have to wait a little longer but we’ve seen the bottom and all looks good.

Some positivity here today. Let’s hope for a better 12 months than the last. I think that as this price we are undervalued and we should see a much better SP soon. Long term lots and lots of potential but some risks attached. ‘He Who Dares’

Looking strong today. Good year ahead coming. Good luck.

98p paid and a cracking day here at OPTI. This must be attracting new investors now as it is one of only a few companies that is moving back to solid territory in this horrible period. Strong buy.

Big buying day today. Surprised we are not up a little more. We are definitely bucking the Brexit Rot. Looking good for tomorrow I should think.

Strong news indeed and the future looking very bright. £1 plus again very soon in my opinion and long term this is looking increadably attractive. Not many companies like this on AIM. Good luck.

Heading towards a possible blue finish.

£1 anytime now.